02256.HK
Abbisko Cayman Limited
HKSE · Healthcare · Biotechnology · CN
HKD 8.30
+0.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.03x
- Price / sales
- 45.56x
- Price / cash flow
- -19.78x
Enterprise value
- Enterprise value
- HKD 2.8B
- EV / sales
- 24.91x
- EV / EBITDA
- -4.76x
- EV / EBIT
- -4.68x
- Market cap
- HKD 5.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026